LAVAL, Quebec, May 10, 2017 /CNW/ -- Valeant
Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today
announced that Joseph C. Papa,
chairman and chief executive officer, is scheduled to present at
the following health care conferences:
- Bank of America Merrill Lynch 2017 Healthcare Conference on
Wednesday, May 17, 2017 at
3:00 p.m. PDT (6:00 p.m. EDT) at the Wynn Las Vegas hotel;
- UBS Global Healthcare Conference to be held on Monday, May 22, 2017 at 9:00 a.m. EDT at the Grand Hyatt New York hotel;
and
- Jefferies 2017 Global Healthcare Conference to be held on
Wednesday, June 7, 2017 at
8:30 a.m. EDT at the Grand Hyatt New
York hotel.
A live webcast and audio archive of the events will be available
on Valeant's Investor Relations website and via this URL:
http://ir.valeant.com/events-and-presentations
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a
multinational specialty pharmaceutical company that develops,
manufactures and markets a broad range of pharmaceutical products
primarily in the areas of dermatology, gastrointestinal disorders,
eye health, neurology and branded generics. More information about
Valeant and forward looking statements can be found at
www.valeant.com.
Contact Information
Investors:
Elif
McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)
Media:
Lainie Keller
lainie.keller@valeant.com
908-927-0617
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-present-at-health-care-conferences-300455523.html
SOURCE Valeant Pharmaceuticals International, Inc.